BRIPOLO
DEAD

Serial Number

90647824

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Xiomara Triana

Filing Date

Apr 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BRIPOLO Trademark

Serial Number: 90647824

BRIPOLO is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on April 15, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,799 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Trademark Details

Filing Date

April 15, 2021

Registration Date

Not Registered

Published for Opposition

January 3, 2023

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 2, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 2, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 28, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 14, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 23, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 23, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 23, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 23, 2022 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 3, 2022 GNFN
FINAL REFUSAL E-MAILED
May 3, 2022 GNFR
FINAL REFUSAL WRITTEN
May 3, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2022 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 8, 2021 GPRN
PRIORITY ACTION E-MAILED
Oct 8, 2021 GPRA
PRIORITY ACTION WRITTEN
Oct 8, 2021 CPRA
ASSIGNED TO EXAMINER
Oct 5, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2021 NWOS
NEW APPLICATION ENTERED
Apr 19, 2021 NWAP